All News #Library
Biotech
Pelthos Doses First Patient in Phase 1b/2a CT2000 Eye Pain Trial
31 Mar 2026 //
GLOBENEWSWIRE
Channel Therapeutics Announces 2024 Report for NYSE Compliance
01 May 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support